{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:21:58Z","timestamp":1792714918325,"version":"4.5.0"},"reference-count":97,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.jaip.2023.01.032","type":"journal-article","created":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T11:51:50Z","timestamp":1675252310000},"page":"1665-1675","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Updated Management Guidelines for Adenosine Deaminase Deficiency"],"prefix":"10.1016","volume":"11","author":[{"given":"Eyal","family":"Grunebaum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Booth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey D.E.","family":"Cuvelier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn","family":"Loves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Aiuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald B.","family":"Kohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2023.01.032_bib1","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0140-6736(72)92345-8","article-title":"Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity","volume":"2","author":"Giblett","year":"1972","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2023.01.032_bib2","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jaci.2018.08.027","article-title":"The genetic landscape of severe combined immunodeficiency in the United States and Canada in the current era (2010-2018)","volume":"143","author":"Dvorak","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.01.032_bib3","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3389\/fimmu.2016.00314","article-title":"Adenosine deaminase deficiency\u2014more than just an immunodeficiency","volume":"7","author":"Whitmore","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2023.01.032_bib4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3389\/fimmu.2012.00265","article-title":"Autoimmune dysregulation and purine metabolism in adenosine deaminase deficiency","volume":"3","author":"Sauer","year":"2012","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2023.01.032_bib5","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1007\/s10875-020-00857-9","article-title":"Adenosine deaminase (ADA)-deficient severe combined immune deficiency (SCID) in the US Immunodeficiency Network (USIDNet) Registry","volume":"40","author":"Kuo","year":"2020","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2023.01.032_bib6","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1469-1809.2006.00338.x","article-title":"Carrier frequency of a nonsense mutation in the adenosine deaminase (ADA) gene implies a high incidence of ADA-deficient severe combined immunodeficiency (SCID) in Somalia and a single, common haplotype indicates common ancestry","volume":"71","author":"Sanchez","year":"2007","journal-title":"Ann Hum Genet"},{"key":"10.1016\/j.jaip.2023.01.032_bib7","first-page":"324","article-title":"Retrospective TREC testing of newborns with severe combined immunodeficiency and other primary immunodeficiency diseases","volume":"1","author":"Jilkina","year":"2014","journal-title":"Mol Genet Metab Rep"},{"key":"10.1016\/j.jaip.2023.01.032_bib8","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1093\/hmg\/4.11.2081","article-title":"Three new adenosine deaminase mutations that define a splicing enhancer and cause severe and partial phenotypes: implications for evolution of a CpG hotspot and expression of a transduced ADA cDNA","volume":"4","author":"Santisteban","year":"1995","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jaip.2023.01.032_bib9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/ajmg.c.20002","article-title":"Pediatric medicine and the genetic disorders of the Amish and Mennonite people of Pennsylvania","volume":"121C","author":"Morton","year":"2003","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.jaip.2023.01.032_bib10","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1007\/s10875-021-01018-2","article-title":"Adenosine deaminase deficient SCID with myocardial hypertrophy","volume":"41","author":"Flinn","year":"2021","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2023.01.032_bib11","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.jaci.2012.08.054","article-title":"Tandem mass spectrometry, but not T-cell receptor excision circle analysis, identifies newborns with late-onset adenosine deaminase deficiency","volume":"131","author":"La Marca","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.01.032_bib12","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/ACI.0000000000000006","article-title":"Recent advances in understanding and managing adenosine deaminase and purine nucleoside phosphorylase deficiencies","volume":"13","author":"Grunebaum","year":"2013","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.01.032_bib13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1055\/s-2007-973552","article-title":"Cytomegalovirus encephalitis in a child with adenosine deaminase-deficient severe combined immune deficiency: a neuropathologic study","volume":"29","author":"Takano","year":"1998","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.jaip.2023.01.032_bib14","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/BF01958426","article-title":"Successful bone marrow transplantation and treatment of BCG infection in two patients with severe combined immunodeficiency","volume":"150","author":"Heyderman","year":"1991","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jaip.2023.01.032_bib15","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJMoa0904485","article-title":"Vaccine-acquired rotavirus in infants with severe combined immunodeficiency","volume":"362","author":"Patel","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.01.032_bib16","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.jaci.2007.12.1148","article-title":"Adenosine deaminase deficiency can present with features of Omenn syndrome","volume":"121","author":"Roifman","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.01.032_bib17","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1182\/blood.2022016196","article-title":"Outcomes following treatment for ADA-deficient severe combined immunodeficiency: a report from the PIDTC","volume":"140","author":"Cuvelier","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2023.01.032_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/srep40136","article-title":"Alterations in the brain adenosine metabolism cause behavioral and neurological impairment in ADA-deficient mice and patients","volume":"7","author":"Sauer","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaip.2023.01.032_bib19","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.pediatrneurol.2007.03.011","article-title":"Neurologic abnormalities in patients with adenosine deaminase deficiency","volume":"37","author":"Nofech-Mozes","year":"2007","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.jaip.2023.01.032_bib20","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s10875-018-0496-9","article-title":"ADA deficiency: evaluation of the clinical and laboratory features and the outcome","volume":"38","author":"Cagdas","year":"2018","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2023.01.032_bib21","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jpeds.2003.10.055","article-title":"Bilateral sensorineural deafness in adenosine deaminase-deficient severe combined immunodeficiency","volume":"144","author":"Albuquerque","year":"2004","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jaip.2023.01.032_bib22","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s10875-021-01145-w","article-title":"Long-term immune recovery after hematopoietic stem cell transplantation for ADA deficiency: a single-center experience","volume":"42","author":"Kreins","year":"2022","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2023.01.032_bib23","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.jaci.2012.02.003","article-title":"Pulmonary alveolar proteinosis in patients with adenosine deaminase deficiency","volume":"129","author":"Grunebaum","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.01.032_bib24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13023-015-0365-z","article-title":"Impulse oscillometry identifies peripheral airway dysfunction in children with adenosine deaminase deficiency","volume":"10","author":"Komarow","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jaip.2023.01.032_bib25","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1056\/NEJM199605233342104","article-title":"Brief report: hepatic dysfunction as a complication of adenosine deaminase deficiency","volume":"334","author":"Bollinger","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.01.032_bib26","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1007\/s10875-020-00777-8","article-title":"Urogenital abnormalities in adenosine deaminase deficiency","volume":"40","author":"Pajno","year":"2020","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2023.01.032_bib27","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1007\/s10875-022-01337-y","article-title":"Adenosine deaminase (ADA) deficiency: report of six new cases and reappraisal of cutaneous hypermelanosis as an early feature","volume":"42","author":"Sharafian","year":"2022","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2023.01.032_bib28","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1172\/JCI116833","article-title":"Novel splicing, missense, and deletion mutations in seven adenosine deaminase-deficient patients with late\/delayed onset of combined immunodeficiency disease. Contribution of genotype to phenotype","volume":"92","author":"Santisteban","year":"1993","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaip.2023.01.032_bib29","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/0140-6736(93)90910-9","article-title":"Adult presentation of adenosine deaminase deficiency","volume":"341","author":"Shovlin","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2023.01.032_bib30","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1182\/blood.V89.8.2849","article-title":"Adenosine deaminase deficiency in adults","volume":"89","author":"Ozsahin","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2023.01.032_bib31","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.jaci.2009.07.003","article-title":"Polyethylene glycol-modified adenosine deaminase improved lung disease but not liver disease in partial adenosine deaminase deficiency","volume":"124","author":"Somech","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.01.032_bib32","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1182\/blood-2011-01-329359","article-title":"Myeloid dysplasia and bone marrow hypocellularity in adenosine deaminase-deficient severe combined immune deficiency","volume":"118","author":"Sokolic","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2023.01.032_bib33","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s10875-015-0158-0","article-title":"Adenosine deaminase deficient severe combined immunodeficiency presenting as atypical haemolytic uraemic syndrome","volume":"35","author":"Nikolajeva","year":"2015","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2023.01.032_bib34","doi-asserted-by":"crossref","first-page":"195","DOI":"10.14785\/lpsn-2015-0010","article-title":"Atypical hemolytic-uremic syndrome in a patient with adenosine deaminase deficiency","volume":"2","author":"Pham-Huy","year":"2015","journal-title":"LymphoSign J"},{"key":"10.1016\/j.jaip.2023.01.032_bib35","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3389\/fimmu.2018.00113","article-title":"First occurrence of plasmablastic lymphoma in adenosine deaminase-deficient severe combined immunodeficiency disease patient and review of the literature","volume":"9","author":"Migliavacca","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2023.01.032_bib36","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.jaci.2011.10.028","article-title":"Multicentric dermatofibrosarcoma protuberans in patients with adenosine deaminase-deficient severe combined immune deficiency","volume":"129","author":"Kesserwan","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.01.032_bib37","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.anai.2022.07.016","article-title":"Newborn tandem mass spectroscopy screening for adenosine deaminase deficiency","volume":"129","author":"Hartog","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2023.01.032_bib38","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jaci.2018.04.029","article-title":"Neutropenia among patients with adenosine deaminase deficiency","volume":"143","author":"Kim","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.01.032_bib39","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/pbc.24353","article-title":"Neutropenia and myeloid dysplasia in a patient with delayed-onset adenosine deaminase deficiency","volume":"60","author":"Nomura","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jaip.2023.01.032_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.748519","article-title":"The use of induced pluripotent stem cells to study the effects of adenosine deaminase deficiency on human neutrophil development","volume":"12","author":"Tsui","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2023.01.032_bib41","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00247-012-2564-2","article-title":"Characteristic scapular and rib changes on chest radiographs of children with ADA-deficiency SCIDS in the first year of life","volume":"43","author":"Manson","year":"2013","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.jaip.2023.01.032_bib42","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10875-019-00733-1","article-title":"Chest radiographs for distinguishing ADA-SCID from other forms of SCID","volume":"40","author":"Verhagen","year":"2020","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2023.01.032_bib43","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.jaci.2018.08.024","article-title":"Consensus approach for the management of severe combined immune deficiency caused by adenosine deaminase deficiency","volume":"143","author":"Kohn","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.01.032_bib44","doi-asserted-by":"crossref","first-page":"135","DOI":"10.14785\/lpsn-2014-0024","article-title":"Tandem mass spectrometric determination of purine metabolites and adenosine deaminase activity for newborn screening of ADA\u2013SCID","volume":"2","author":"Al-Dirbashi","year":"2015","journal-title":"LymphoSign J"},{"key":"10.1016\/j.jaip.2023.01.032_bib45","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/0-306-46843-3_10","article-title":"ADA activity and DATP levels in erythrocytes after bone marrow transplantation","volume":"486","author":"Fairbanks","year":"2000","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jaip.2023.01.032_bib46","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/978-1-0716-2565-1_37","article-title":"Quantitation of purine in urine by ultra-performance liquid chromatography-tandem mass spectrometry","volume":"2546","author":"Sun","year":"2022","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jaip.2023.01.032_bib47","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1086\/302054","article-title":"Adenosine deaminase deficiency: genotype-phenotype correlations based on expressed activity of 29 mutant alleles","volume":"63","author":"Arredondo-Vega","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jaip.2023.01.032_bib48","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/s10875-015-0191-z","article-title":"Diagnosis, treatment and long-term follow up of patients with ADA deficiency: a single-center experience","volume":"35","author":"Baffelli","year":"2015","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2023.01.032_bib49","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1203\/00006450-199333011-00008","article-title":"Overview of biochemical abnormalities and molecular genetics of adenosine deaminase deficiency","volume":"33","author":"Hirschhorn","year":"1993","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jaip.2023.01.032_bib50","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1182\/blood-2011-07-366781","article-title":"Alterations in the adenosine metabolism and CD39\/CD73 adenosinergic machinery cause loss of Treg cell function and autoimmunity in ADA-deficient SCID","volume":"119","author":"Sauer","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2023.01.032_bib51","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s10875-020-00865-9","article-title":"Infections in infants with SCID: isolation, infection screening, and prophylaxis in PIDTC centers","volume":"41","author":"Dorsey","year":"2021","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2023.01.032_bib52","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1056\/NEJM197612092952402","article-title":"Enzyme replacement therapy for adenosine deaminase deficiency and severe combined immunodeficiency","volume":"295","author":"Polmar","year":"1976","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.01.032_bib53","first-page":"649","article-title":"Alteration of the circulating life and antigenic properties of bovine adenosine deaminase in mice by attachment of polyethylene glycol","volume":"46","author":"Davis","year":"1981","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaip.2023.01.032_bib54","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJM198703053161005","article-title":"Treatment of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase","volume":"316","author":"Hershfield","year":"1987","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.01.032_bib55","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1182\/blood.V80.5.1163.1163","article-title":"Antibody responses to bacteriophage phi X174 in patients with adenosine deaminase deficiency","volume":"80","author":"Ochs","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2023.01.032_bib56","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1172\/JCI116626","article-title":"T\u00a0lymphocyte ontogeny in adenosine deaminase-deficient severe combined immune deficiency after treatment with polyethylene glycol-modified adenosine deaminase","volume":"92","author":"Weinberg","year":"1993","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaip.2023.01.032_bib57","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.clim.2005.07.006","article-title":"Long-term efficacy of enzyme replacement therapy for adenosine deaminase (ADA)-deficient severe combined immunodeficiency (SCID)","volume":"117","author":"Chan","year":"2005","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaip.2023.01.032_bib58","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1002\/eji.200526248","article-title":"Reduced thymic output, increased spontaneous apoptosis and oligoclonal B cells in polyethylene glycoladenosine deaminase-treated patients","volume":"35","author":"Malacarne","year":"2005","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaip.2023.01.032_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2019.108321","article-title":"Morbidity in an adenosine deaminase-deficient patient during 27 years of enzyme replacement therapy","volume":"211","author":"Grunebaum","year":"2020","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaip.2023.01.032_bib60","doi-asserted-by":"crossref","first-page":"e876","DOI":"10.1542\/peds.2005-1068","article-title":"Cerebral lymphoma in an adenosine deaminase-deficient patient with severe combined immunodeficiency receiving polyethylene glycol-conjugated adenosine deaminase","volume":"116","author":"Kaufman","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaip.2023.01.032_bib61","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1172\/JCI115761","article-title":"IgG antibody response to polyethylene glycol-modified adenosine deaminase in patients with adenosine deaminase deficiency","volume":"89","author":"Chaffee","year":"1992","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaip.2023.01.032_bib62","first-page":"349","article-title":"Pegademase bovine (PEG-ADA) for the treatment of infants and children with severe combined immunodeficiency (SCID)","volume":"3","author":"Booth","year":"2009","journal-title":"Biologics"},{"key":"10.1016\/j.jaip.2023.01.032_bib63","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/cei.13420","article-title":"Comparison of elapegademase and pegademase in ADA-deficient patients and mice","volume":"200","author":"Murguia-Favela","year":"2020","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaip.2023.01.032_bib64","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.jaip.2023.01.028","article-title":"Long-term immune reconstitution in ADA-deficient patients treated with elapegademase: a real-world experience","volume":"11","author":"Murguia-Favela","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.01.032_bib65","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1182\/blood-2006-07-034678","article-title":"Patients with adenosine deaminase deficiency surviving after hematopoietic stem cell transplantation are at high risk of CNS complications","volume":"109","author":"H\u00f6nig","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2023.01.032_bib66","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1182\/blood-2011-12-396879","article-title":"Outcome of hematopoietic stem cell transplantation for adenosine deaminase-deficient severe combined immunodeficiency","volume":"120","author":"Hassan","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2023.01.032_bib67","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s10875-022-01238-0","article-title":"Hematopoietic cell transplantation for adenosine deaminase severe combined immunodeficiency\u2014improved outcomes in the modern era","volume":"42","author":"Ghimenton","year":"2022","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2023.01.032_bib68","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12026-010-8191-9","article-title":"Transplantation of hematopoietic stem cells in human severe combined immunodeficiency: longterm outcomes","volume":"49","author":"Buckley","year":"2011","journal-title":"Immunol Res"},{"key":"10.1016\/j.jaip.2023.01.032_bib69","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0140-6736(03)12513-5","article-title":"Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99","volume":"361","author":"Antoine","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2023.01.032_bib70","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s10875-017-0373-y","article-title":"How we manage adenosine deaminase-deficient severe combined immune deficiency (ADA SCID)","volume":"37","author":"Kohn","year":"2017","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2023.01.032_bib71","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1089\/hum.1993.4.4-521","volume":"4","author":"Blaese","year":"1993","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.jaip.2023.01.032_bib72","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/nm1095-1017","article-title":"Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency","volume":"1","author":"Kohn","year":"1995","journal-title":"Nat Med"},{"key":"10.1016\/j.jaip.2023.01.032_bib73","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1089\/hum.1993.4.4-513","article-title":"Transfer of the ADA gene into bone marrow cells and peripheral blood lymphocytes for the treatment of patients affected by ADA-deficient SCID","volume":"4","author":"Bordignon","year":"1993","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.jaip.2023.01.032_bib74","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1126\/science.270.5235.470","article-title":"Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients","volume":"270","author":"Bordignon","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.jaip.2023.01.032_bib75","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nm844","article-title":"Clonality analysis after retroviral-mediated gene transfer to CD34+ cells from the cord blood of ADA-deficient SCID neonates","volume":"9","author":"Schmidt","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.jaip.2023.01.032_bib76","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/s41467-022-28762-2","article-title":"A\u00a0systematic review and meta-analysis of gene therapy with hematopoietic stem and progenitor cells for monogenic disorders","volume":"13","author":"Tucci","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaip.2023.01.032_bib77","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1126\/science.270.5235.475","article-title":"T\u00a0lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 years","volume":"270","author":"Blaese","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.jaip.2023.01.032_bib78","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.omtm.2021.10.003","article-title":"Nonconditioned ADA-SCID gene therapy reveals ADA requirement in the hematopoietic system and clonal dominance of vector-marked clones","volume":"23","author":"Uchiyama","year":"2021","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.jaip.2023.01.032_bib79","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1126\/science.1070104","article-title":"Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning","volume":"296","author":"Aiuti","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jaip.2023.01.032_bib80","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1182\/blood-2012-02-400937","article-title":"Gene therapy for adenosine deaminase-deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans","volume":"120","author":"Candotti","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2023.01.032_bib81","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ymthe.2006.06.007","article-title":"Successful reconstitution of immunity in ADA-SCID by stem cell gene therapy following cessation of PEG-ADA and use of mild preconditioning","volume":"14","author":"Gaspar","year":"2006","journal-title":"Mol Ther"},{"key":"10.1016\/j.jaip.2023.01.032_bib82","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002716","article-title":"Hematopoietic stem cell gene therapy for adenosine deaminase-deficient severe combined immunodeficiency leads to long-term immunological recovery and metabolic correction","volume":"3","author":"Gaspar","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaip.2023.01.032_bib83","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1172\/JCI90367","article-title":"Clinical efficacy of gene-modified stem cells in adenosine deaminase-deficient immunodeficiency","volume":"127","author":"Shaw","year":"2017","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaip.2023.01.032_bib84","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1182\/blood.2020010260","article-title":"Long-term outcomes after gene therapy for adenosine deaminase severe combined immune deficiency","volume":"138","author":"Reinhardt","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2023.01.032_bib85","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1182\/blood-2016-01-688226","article-title":"Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency","volume":"128","author":"Cicalese","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2023.01.032_bib86","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1038\/s41591-022-01934-9","article-title":"Ensuring a future for gene therapy for rare diseases","volume":"28","author":"Aiuti","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.jaip.2023.01.032_bib87","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/mt.2013.265","article-title":"Preclinical demonstration of lentiviral vector-mediated correction of immunological and metabolic abnormalities in models of adenosine deaminase deficiency","volume":"22","author":"Carbonaro","year":"2014","journal-title":"Mol Ther"},{"key":"10.1016\/j.jaip.2023.01.032_bib88","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1056\/NEJMoa2027675","article-title":"Autologous ex\u00a0vivo lentiviral gene therapy for adenosine deaminase deficiency","volume":"384","author":"Kohn","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.01.032_bib89","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.jaci.2012.04.004","article-title":"Delayed-onset adenosine deaminase deficiency: strategies for an early diagnosis","volume":"130","author":"Speckmann","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.01.032_bib90","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1182\/blood.2022015506","article-title":"Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP study","volume":"140","author":"Albert","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2023.01.032_bib91","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1399-3046.2012.01762.x","article-title":"Successful bone marrow transplantation with reduced intensity conditioning in a patient with delayed-onset adenosine deaminase deficiency","volume":"17","author":"Kanegane","year":"2013","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jaip.2023.01.032_bib92","doi-asserted-by":"crossref","first-page":"335ra57","DOI":"10.1126\/scitranslmed.aad8856","article-title":"Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency","volume":"8","author":"De Ravin","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaip.2023.01.032_bib93","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.clim.2006.12.009","article-title":"Management options for adenosine deaminase deficiency; proceedings of the EBMT satellite workshop (Hamburg, March 2006)","volume":"123","author":"Booth","year":"2007","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaip.2023.01.032_bib94","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1182\/blood-2009-06-189209","article-title":"How I treat ADA deficiency","volume":"114","author":"Gaspar","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2023.01.032_bib95","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13023-018-0807-5","article-title":"Adenosine deaminase deficiency: a review","volume":"13","author":"Flinn","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jaip.2023.01.032_bib96","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1038\/s41409-021-01378-8","article-title":"EBMT\/ESID inborn errors working party guidelines for hematopoietic stem cell transplantation for inborn errors of immunity","volume":"56","author":"Lankester","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaip.2023.01.032_bib97","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s10875-022-01239-z","article-title":"TCR\u03b1\u03b2-depleted haploidentical grafts are a safe alternative to HLA-matched unrelated donor stem cell transplants for infants with severe combined immunodeficiency","volume":"42","author":"Flood","year":"2022","journal-title":"J\u00a0Clin Immunol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219823001186?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219823001186?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:37:14Z","timestamp":1761975434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219823001186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":97,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S2213219823001186"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2023.01.032","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Updated Management Guidelines for Adenosine Deaminase Deficiency","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2023.01.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}